At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized, Double Blind, Comparison of Standard Dose Trivalent Inactivated Influenza Vaccine Versus High Dose Trivalent Inactivated Influenza Vaccine in Pediatric Patients With Acute Lymphoblastic Leukemia
In Brief
A Phase 1 clinical trial evaluating High-dose trivalent inactivated influenza vaccine and Standard dose trivalent inactivated influenza vaccine for Pediatric Patients With Acute Lymphoblastic Leukemia. Completed, enrolled 50 participants across 1 site.
Detailed Summary
This is a phase I safety and immunogenicity trial comparing high-dose (HD)trivalent inactivated influenza vaccine (TIV) to standard dose (SD) TIV in pediatric patients with Acute Lymphoblastic Leukemia.
Study Details
Timeline
Interventions
0.5 mL of high-dose trivalent inactivated influenza vaccine, either one dose or 2 based on whether the patient has previously received standard dose trivalent inactivated influenza vaccine.
0.5 mL standard dose trivalent inactivated influenza vaccine